,10 For example, recent work has shown that Alzheimer’s disease risk variants can affect miRNA binding,11 can be located within enhancers and within CTCF sites, thus altering chromatin states12,13 and they can be located specifically in microglial enhancers14 thus affecting gene expression in the brain. This evidence concerns the gene CTCF and Alzheimer disease.